PACS Group (NYSE:PACS) Stock Price Expected to Rise, UBS Group Analyst Says

PACS Group (NYSE:PACSGet Free Report) had its price target lifted by investment analysts at UBS Group from $42.00 to $44.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group’s price target would indicate a potential upside of 15.42% from the stock’s previous close.

Several other equities research analysts have also issued reports on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of PACS Group in a research note on Monday, December 22nd. Royal Bank Of Canada raised their price objective on PACS Group from $47.00 to $52.00 and gave the company an “outperform” rating in a report on Friday, February 27th. Wall Street Zen upgraded PACS Group from a “hold” rating to a “buy” rating in a research report on Sunday, February 15th. Truist Financial set a $40.00 price target on shares of PACS Group in a research report on Friday, December 12th. Finally, JPMorgan Chase & Co. initiated coverage on shares of PACS Group in a research note on Wednesday, December 17th. They set an “overweight” rating and a $44.00 price target on the stock. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, PACS Group presently has an average rating of “Moderate Buy” and an average target price of $44.40.

Read Our Latest Research Report on PACS Group

PACS Group Price Performance

NYSE:PACS traded up $1.25 during midday trading on Wednesday, hitting $38.12. The company had a trading volume of 133,344 shares, compared to its average volume of 1,096,220. PACS Group has a 52-week low of $7.50 and a 52-week high of $43.08. The stock’s fifty day moving average price is $38.17 and its 200-day moving average price is $24.80. The company has a market capitalization of $5.99 billion, a PE ratio of 30.99, a P/E/G ratio of 1.26 and a beta of -0.64. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.28.

Institutional Investors Weigh In On PACS Group

Several institutional investors and hedge funds have recently bought and sold shares of PACS. Hollencrest Capital Management purchased a new stake in shares of PACS Group during the 4th quarter valued at about $27,000. Quarry LP grew its position in PACS Group by 79.5% during the third quarter. Quarry LP now owns 2,388 shares of the company’s stock valued at $33,000 after buying an additional 1,058 shares during the period. Larson Financial Group LLC grew its position in PACS Group by 127.0% during the fourth quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock valued at $42,000 after buying an additional 612 shares during the period. Strategic Advocates LLC purchased a new stake in PACS Group during the third quarter valued at approximately $60,000. Finally, Jones Financial Companies Lllp bought a new position in PACS Group in the first quarter worth approximately $64,000.

About PACS Group

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Further Reading

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.